BIOMAT Database Logo BIOMAT Database Logo

Chemical and biological properties of cytotoxic alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. 1995

M C Liu, and T S Lin, and A C Sartorelli
Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012262 Ribonucleoside Diphosphate Reductase An enzyme of the oxidoreductase class that catalyzes the formation of 2'-deoxyribonucleotides from the corresponding ribonucleotides using NADPH as the ultimate electron donor. The deoxyribonucleoside diphosphates are used in DNA synthesis. (From Dorland, 27th ed) EC 1.17.4.1. UDP Reductase,Diphosphate Reductase, Ribonucleoside,Reductase, Ribonucleoside Diphosphate,Reductase, UDP
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013882 Thiosemicarbazones Thiosemicarbazone
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M C Liu, and T S Lin, and A C Sartorelli
The chemistry and biological activity of alpha -(N)-heterocyclic carboxaldehyde thiosemicarbazones.
January 1978, Progress in medicinal chemistry,
M C Liu, and T S Lin, and A C Sartorelli
Inhibition of ribonucleotide reductase by alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones.
January 1984, Pharmacology & therapeutics,
M C Liu, and T S Lin, and A C Sartorelli
Comparative cytotoxic and biochemical effects of ligands and metal complexes of alpha-N-heterocyclic carboxaldehyde thiosemicarbazones.
October 1979, Journal of medicinal chemistry,
M C Liu, and T S Lin, and A C Sartorelli
The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone.
October 1965, Cancer research,
M C Liu, and T S Lin, and A C Sartorelli
The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone.
August 1966, Cancer research,
M C Liu, and T S Lin, and A C Sartorelli
Studies on the mechanism of action of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones.
January 1972, Advances in biology of skin,
M C Liu, and T S Lin, and A C Sartorelli
Potential antitumor agents. 3. Sodium salts of alpha-[N]-heterocyclic carboxaldehyde thiosemicarbazones.
November 1968, Journal of pharmaceutical sciences,
M C Liu, and T S Lin, and A C Sartorelli
Characterization of the biochemical mechanism of action of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones.
January 1976, Advances in enzyme regulation,
M C Liu, and T S Lin, and A C Sartorelli
Potential antitumor agents. 5. Methylated -(N)-heterocyclic carboxaldehyde thiosemicarbazones.
February 1972, Journal of medicinal chemistry,
M C Liu, and T S Lin, and A C Sartorelli
Potential antitumor agents. 7. 4'-Diethyleneoxy derivatives of -(N)-heterocyclic carboxaldehyde thiosemicarbazones.
June 1973, Journal of medicinal chemistry,
Copied contents to your clipboard!